Álvarez-Román, M.T., Cuervo-Arango, I., Pérez-Santamarina, R., Poveda, J.L., Romero, J.A., Santamaría, A., Trillo-Mata, J.L., Tort, M. and Badia, X. 2019. Determining the value contribution of emicizumab (Hemlibra®) for the prophylaxis of haemophilia A with inhibitors in Spain by multi-criteria decision analysis. Global and Regional Health Technology Assessment. 6, 1 (Oct. 2019). DOI:https://doi.org/10.33393/grhta.2019.452.